Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of August 28. Aside from presenting a synopsis of events, we provide
For roughly 80% of breast cancer survivors, treatment doesn’t end with surgery, radiation and chemotherapy. Instead, for the next five to 10 years, doctors recommend
Despite advances in treatment for high cholesterol, heart disease remains the leading cause of death in the U.S. Scientists at the Medical College of Wisconsin
Backed by a $26 million federal grant, researchers at three Michigan universities, a leading health care system, and a state agency will continue a long-term
Bayer is working on expanding the label for its chronic kidney disease drug Kerendia, announcing three new trials to investigate it as a treatment for
GSK is investing about $270 million (€250 million) to build out and expand its vaccine manufacturing facilities in Wavre, Belgium. The plant is expected to
FDA on Friday published draft guidance laying out its approach to post-warning letter meetings for generic drugmakers, including the criteria for granting the meetings and
The European Medicines Agency’s safety committee has issued a new warning against using topiramate, a drug commonly used to treat epilepsy and migraines, during pregnancy.
While finance and tech are leading the way to the first-ever year of $1 trillion in ad spending, the pharma and healthcare category is right
A new film about a global disease threat lays out dire scenarios that echo Hollywood disaster movie plotlines. Antimicrobial resistance (AMR), however, is very real